Coherus BioSciences, Inc. (CHRS) Ownership
CHRS ownership summary
as of October 18, 2026- Institutions
- 37.5% of shares outstanding
- Insiders
- 19.12% of shares outstanding
- Shares outstanding
- 154.5M
- Float
- 135.6M shares available to trade
- Short interest
- 15.56% 23.3M shares short
- Days to cover
- 17.72 short interest up 2.1% vs prior month
- Institutions 37.45%
- Insiders 19.12%
- Other investors 43.43%
CHRS top institutional holders
20 largest| # | Holder | % of shares | Shares | Value | Change | Reported |
|---|---|---|---|---|---|---|
| 1 | Timothy G. Youngquist 2020 Irrevocable Trust | 8.45% | 13.1M | $12.9M | +759,823 (+6.2%) | June 30, 2026 |
| 2 | BlackRock Inc | 7.77% | 12.0M | $11.9M | +1.6M (+15.8%) | June 30, 2026 |
| 3 | Vanguard Capital Management, LLC | 3.85% | 5.9M | $5.9M | +496,728 (+9.1%) | June 30, 2026 |
| 4 | Geode Capital Management, LLC | 2.39% | 3.7M | $3.6M | +563,989 (+18.1%) | June 30, 2026 |
| 5 | Samsara BioCapital, LLC | 2.22% | 3.4M | $3.4M | — | June 30, 2026 |
| 6 | Kohlberg Kravis Roberts & Co LP | 1.97% | 3.0M | $3.0M | — | June 30, 2026 |
| 7 | State Street Corp | 1.54% | 2.4M | $2.4M | +56,446 (+2.4%) | June 30, 2026 |
| 8 | Two Sigma Investments LLC | 1.46% | 2.3M | $2.2M | −42,589 (−1.9%) | June 30, 2026 |
| 9 | CM Management, LLC | 1.36% | 2.1M | $2.1M | — | June 30, 2026 |
| 10 | CAM Group Holding A/S | 1.25% | 1.9M | $1.9M | — | June 30, 2026 |
| 11 | Alyeska Investment Group, L.P. | 1.12% | 1.7M | $1.7M | −516,766 (−23.0%) | June 30, 2026 |
| 12 | Hudson Bay Capital Management LP | 1.10% | 1.7M | $1.7M | −11,980 (−0.7%) | June 30, 2026 |
| 13 | AQR Capital Management LLC | 0.86% | 1.3M | $1.3M | +124,155 (+10.3%) | June 30, 2026 |
| 14 | Charles Schwab Investment Management Inc | 0.79% | 1.2M | $1.2M | +72,168 (+6.2%) | June 30, 2026 |
| 15 | Panagora Asset Management Inc | 0.74% | 1.1M | $1.1M | −321,985 (−22.1%) | June 30, 2026 |
| 16 | Northern Trust Corp | 0.73% | 1.1M | $1.1M | +215,670 (+23.6%) | June 30, 2026 |
| 17 | Vanguard Fiduciary Trust Co | 0.66% | 1.0M | $1.0M | +66,072 (+7.0%) | June 30, 2026 |
| 18 | Delaware Management Holdings Inc | 0.58% | 900K | $890,999 | — | June 30, 2026 |
| 19 | Vanguard Portfolio Management, LLC | 0.57% | 883K | $874,619 | +278,929 (+46.1%) | June 30, 2026 |
| 20 | UBS Group AG | 0.49% | 760K | $752,754 | +213,149 (+39.0%) | June 30, 2026 |
Value at the latest close. Change = shares bought or sold in the latest quarterly filing (13F). In the top 20, 11 holders added 4.5M shares and 4 cut 893K.
CHRS top mutual fund and ETF holders
20 largest| # | Holder | % of shares | Shares | Value | Change | Reported |
|---|---|---|---|---|---|---|
| 1 | iShares Russell 2000 ETF | 4.23% | 6.5M | $6.5M | +3.3M (+100.0%) | September 30, 2026 |
| 2 | Vanguard MStar Total Stk Mkt Idx Invest | 2.56% | 4.0M | $3.9M | — | August 31, 2026 |
| 3 | HBM Healthcare Investments AG Ord | 2.40% | 3.7M | $3.7M | — | June 30, 2026 |
| 4 | C WorldWide Healthcare Select 1A | 1.25% | 1.9M | $1.9M | — | June 30, 2026 |
| 5 | iShares Russell 2000 Value ETF | 0.96% | 1.5M | $1.5M | +743,799 (+100.0%) | September 30, 2026 |
| 6 | Fidelity Small Cap Index | 0.92% | 1.4M | $1.4M | −1,752 (−0.1%) | July 31, 2026 |
| 7 | BlackRock Advantage Small Cap Core Instl | 0.60% | 928K | $918,552 | — | August 31, 2026 |
| 8 | Nomura Healthcare Fund Class I | 0.58% | 900K | $891,000 | — | August 31, 2026 |
| 9 | iShares Russell 2000 Growth ETF | 0.57% | 882K | $873,659 | +441,242 (+100.0%) | September 30, 2026 |
| 10 | iShares Micro-Cap ETF | 0.50% | 776K | $768,254 | +388,007 (+100.0%) | September 30, 2026 |
| 11 | Fidelity Extended Market Index | 0.49% | 763K | $755,363 | +7,063 (+0.9%) | August 31, 2026 |
| 12 | Vanguard Russell 2000 ETF | 0.48% | 749K | $741,511 | +14,880 (+2.0%) | August 31, 2026 |
| 13 | Schwab US Small-Cap ETF™ | 0.45% | 697K | $689,723 | +468 (+0.1%) | September 30, 2026 |
| 14 | BSF Systematic US Eq Abs Ret A2 USD | 0.26% | 399K | $394,608 | — | December 31, 2025 |
| 15 | Schwab Small Cap Index | 0.21% | 318K | $315,004 | — | August 31, 2026 |
| 16 | iShares Russell 2000 Small-Cap Idx Instl | 0.18% | 274K | $271,505 | — | August 31, 2026 |
| 17 | Fidelity Total Market Index | 0.18% | 271K | $268,693 | +3,772 (+1.4%) | August 31, 2026 |
| 18 | Fidelity Series Total Market Index | 0.15% | 237K | $234,998 | +10,220 (+4.5%) | August 31, 2026 |
| 19 | Invesco RAFI US 1500 Small-Mid ETF | 0.14% | 211K | $208,580 | — | September 30, 2026 |
| 20 | Bridgeway Ultra-Small Company | 0.12% | 191K | $189,090 | −100,000 (−34.4%) | June 30, 2026 |
Funds report holdings monthly or quarterly; dates differ by fund.
CHRS insider transactions
latest 1| Date | Name | Transaction | Price | Shares | Value |
|---|---|---|---|---|---|
| 2025-05-23 | Mats Wahlstrom | Sell | $0.74 | 99,988 | $73,991 |
Reported trades by company officers, directors and other filers (including disclosures by members of Congress where EODHD lists them). "—" where the filing gives no share count.
CHRS shares outstanding
Year-end shares outstanding, adjusted for splits.
Who owns CHRS
Institutional investors own 37.5% of Coherus BioSciences's shares and insiders 19.12%. The largest holder is Timothy G. Youngquist 2020 Irrevocable Trust with 8.45% of the shares (13.1M), as of June 30, 2026. Among the top 20 institutions, 11 added shares and 4 reduced their stake in the latest filings. Short interest is 15.56% of the float, or 17.72 days of average trading volume. The share count rose 506.6% since 2014.
Related: CHRS analyst forecast, CHRS key metrics. See the CHRS stock overview for the latest quote and news.
CHRS ownership FAQ
Who owns the most Coherus BioSciences stock?
The largest shareholders of Coherus BioSciences are Timothy G. Youngquist 2020 Irrevocable Trust (8.45%), BlackRock Inc (7.77%), Vanguard Capital Management, LLC (3.85%), Geode Capital Management, LLC (2.39%), Samsara BioCapital, LLC (2.22%).
What percentage of Coherus BioSciences is owned by institutions?
Institutions hold 37.5% of Coherus BioSciences's shares outstanding; insiders hold 19.12%.
Which funds own Coherus BioSciences?
The largest fund holders of Coherus BioSciences are iShares Russell 2000 ETF (4.23%), Vanguard MStar Total Stk Mkt Idx Invest (2.56%), HBM Healthcare Investments AG Ord (2.40%), C WorldWide Healthcare Select 1A (1.25%), iShares Russell 2000 Value ETF (0.96%).
What is Coherus BioSciences's short interest?
23.3M shares of Coherus BioSciences were sold short, 15.56% of the float; at the average daily volume it would take 17.72 days to cover.
Are insiders buying or selling Coherus BioSciences?
Of the latest 1 reported insider transactions in Coherus BioSciences (since May 23, 2025), 0 were purchases and 1 were sales.
How many shares of Coherus BioSciences are outstanding?
Coherus BioSciences has 154.5M shares outstanding, of which 135.6M are in the public float.